Kathryn Atkins, Author at Oncotarget

Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev?

In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more

December 8, 2022

In a new study, researchers aimed to identify and validate predictive biomarkers of response to... read more

November 15, 2022

Researchers published a research perspective about a recent study that uncovered FSP1 as a novel... read more

November 2, 2022

Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more

October 19, 2022

In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more

October 7, 2022

In a new study, researchers evaluated the high altitude in Ecuador and how it may... read more

September 27, 2022

Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more

September 23, 2022

Researchers investigated common gut microbiome features of response among immunotherapy patients with different advanced-stage cancers.... read more

September 1, 2022

In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more

August 24, 2022

Researchers found that diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence... read more

August 5, 2022